Search and Filter
Results per Page:
New funding drives six breast cancer studies
Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation
Dr. Mazyar Shadman, new medical director of the Bezos Family Immunotherapy Clinic, says immunotherapy services are expanding to meet demand
Increasing timely access to immunotherapy is a main goal
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
Reducing frequency of immunotherapy dosing could save money and time, keep patients on therapy longer
Study of immune checkpoint inhibitor dosing in patients with advanced skin cancers could help guide long-term treatment plans
Multiple myeloma research to be presented at American Society of Hematology annual meeting
Dr. Rahul Banerjee to share insights on reducing financial toxicity, time toxicity and side effects of treatment
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
Bioengineer Aaron Ring receives Anderson Family Endowed Chair for Immunotherapy
Chair will support innovative immunotherapeutic approaches to cancer drug target discovery
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising
Peripheral neuropathy: When having no pain is a big problem
Chemotherapy-induced nerve damage is common for cancer patients and difficult to treat
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
Dr. Fred Appelbaum receives Lifetime Achievement award
Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
Leader in apheresis and cellular therapy, Dr. Michael Linenberger, retires
As professor emeritus, this respected mentor will continue to contribute to the UW fellowship program
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Fred Hutch/UW/Seattle Children’s Cancer Consortium breast cancer researchers receive grants
Breast Cancer Research Foundation supports projects including new imaging tracer, better risk prediction for luminal B subtypes, anti-inflammatory vaccine and more
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Hutch scientists receive $25M to solve breast cancer metastasis
New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Dr. Brenda Sandmaier named president of American Society for Transplantation and Cellular Therapy
Transplant immunotherapy physician-scientist will serve 2022-2023 term
How zinc boosts the immune system
In mice, mineral improves regeneration of key immune organ and immune-cell recovery after bone marrow transplant
Science Says: Comedian, researchers tackle tough topics
Trevor Noah and scientists discuss colorectal cancer screening, community involvement in research, science communication